Lei Jianping on the 26th of the month
Shenzhen BGI Genomics Co., Ltd. (stock code: 300676, stock abbreviation: BGI) announced today that BGI's revenue in the first quarter of 2024 was 821 million yuan, down 14% from 955 million yuan in the same period last year.
BGI's government subsidy in the first quarter of 2024 is 12.16 million yuan.
BGI's net profit in the first quarter of 2024 was 12.4 million yuan, down 69.91% from 41.21 million yuan in the same period last year, and the net profit after deducting non-profits was 2.28 million yuan, down 92.69% from 31.15 million yuan in the same period last year.
Hong Kong Securities Clearing Company Limited withdrew from the top 10 shareholders
As of March 31, 2024, BGI held 35.94% of the shares, Shenzhen Qianhai BGI Investment Enterprise (Limited Partnership) held 8.33% of the shares, Bank of Communications Co., Ltd. - Wanjia Industry Preferred Hybrid Securities Investment Fund (LOF) held 2.42% of the shares, and Bank of China Co., Ltd. - Huabao CSI Healthcare Exchange-traded Open-ended Index Securities Investment Fund held 1.76% of the shares;
As of March 31, 2024, BGI's shareholding structure
Industrial and Commercial Bank of China Co., Ltd. - E Fund ChiNext ETF holds 1.17% of the shares, Shenzhen BGI Co., Ltd. - Phase II Employee Stock Ownership Plan holds 0.97%, and Shenzhen BGI Sanshengyuan Technology Co., Ltd. holds 0.95%;
Agricultural Bank of China Co., Ltd.-CSI 500 ETF holds 0.73%, He Qianxing holds 0.68%, and Wang Jian directly holds 0.61%.
Wang Jian is the controlling shareholder of Shenzhen BGI Genomics Technology Co., Ltd. (BGI), which is the controlling shareholder of Shenzhen BGI Sanshengyuan Technology Co., Ltd. (BGI), and Wang Jian, the chairman and general manager of BGI, is a director of BGI.
As of December 31, 2023, BGI held 35.94% of the shares, Shenzhen Qianhai BGI Investment Enterprise (Limited Partnership) held 8.33% of the shares, Bank of Communications Co., Ltd. - Wanjia Industry Preferred Hybrid Securities Investment Fund (LOF) held 2.42%, Bank of China Co., Ltd. - Huabao CSI Healthcare ETF held 1.77% of the shares, and Hong Kong Securities Clearing Co., Ltd. held 1.38% of the shares , Shenzhen BGI Genomics Co., Ltd. - Phase II Employee Stock Ownership Plan holds 0.97% of the shares, and Shenzhen BGI Sanshengyuan Technology Co., Ltd. holds 0.95% of the shares;
As of December 31, 2023, BGI's equity
Industrial and Commercial Bank of China Co., Ltd.-E Fund ChiNext ETF holds 0.83% of the shares, He Qianxing holds 0.68% of the shares, and Wang Jian directly holds 0.61% of the shares.
The comparison shows that Hong Kong Securities Clearing Co., Ltd. will withdraw from the list of major shareholders in the first quarter of 2024.
As of today's close, BGI's share price was 39.74 yuan, with a market value of 16.449 billion yuan.
———————————————
Lei Di was founded by Lei Jianping, a media person, if it is reprinted, please indicate the source.